hespecta
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02821494)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hespecta
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02821494 | Phase 1 | Mar 1, 2015 | Dutch Cancer Society, ISA Pharmaceuticals, Leiden University, Top Institute Pharma |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dutch Cancer Society | Academic/Hospital | 1 | 0 | 1 | 2015 |
| ISA Pharmaceuticals | For profit | 1 | 0 | 1 | 2015 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Top Institute Pharma | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1